| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| | 10-K | 10-K | 10-K | S-1/A |
| Net sales | 704.3 | 598.4 | 282.3 | 148.2 |
| Net sales growth | 17.7% | 112.0% | 90.4% | |
| Cost of sales: | | | | |
| Cost of product (excluding amortization) | 177.2 | 116.6 | 96.6 | |
| Amortization of patented formulations | 7.5 | 8.0 | 6.1 | |
| Total cost of sales | 184.7 | 124.5 | 102.7 | |
| Gross profit | 519.6 | 473.8 | 179.6 | 117.0 |
| Gross margin | 73.8% | 79.2% | 63.6% | |
| |
| Operating expenses: | | | | |
| Selling, general, and administrative | 113.9 | 98.9 | 37.2 | 56.7 |
| Amortization of other intangible assets | 41.3 | 40.8 | 39.8 | |
| Total operating expenses | 155.2 | 139.7 | 93.5 | 56.7 |
| Operating income | 364.4 | 334.2 | 86.1 | 60.3 |
| Operating margin | 51.7% | 55.8% | 30.5% | |
| Interest expense, net | -41.2 | -61.1 | -38.6 | |
| |
| Other expense, net | | | | |
| Loss on extinguishment of debt | -18.8 | | | |
| Other expense, net | -2.3 | -1.0 | -0.2 | |
| Total other expense, net | -18.0 | 2.6 | -0.2 | 0.5 |
| Income before provision for income taxes | 305.2 | 275.6 | 47.3 | |
| Income tax provision | 61.2 | 54.8 | 8.0 | |
| Net income | 244.1 | 220.8 | 39.3 | 60.9 |
| |
| Net income per share: | | | | |
| Basic (in usd per share) | $0.38 | $0.34 | $0.06 | $60.88 |
| Diluted (in usd per share) | $0.35 | $0.32 | $0.06 | $60.88 |
| |
| Weighted average common shares outstanding: | | | | |
| Weighted average common shares outstanding: Basic (in shares) | 649.1 | 648.2 | 635.4 | 1.0 |
| Weighted average common shares outstanding: Diluted (in shares) | 691.0 | 689.9 | 636.8 | 1.0 |
| |
| Other comprehensive income: | | | | |
| |
| Total other comprehensive income: | | | | |
| Comprehensive income: | 246.6 | 220.8 | 39.3 | 60.9 |